<ѻý>Could Gallstone Disease Predict Pancreatic Cancer?ѻý> Researchers urge more attention to gallstone disease patients with atypical symptoms May 13, 2022
<ѻý>Elotuzumab Combination Disappoints in Newly Diagnosed Myelomaѻý> Study failed to replicate positive results seen in relapsed/refractory setting May 11, 2022
<ѻý>Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapyѻý> Preliminary data on acitretin therapy are promising May 11, 2022
<ѻý>Self-Collected Menstrual Blood to Detect HPV?ѻý> "Not just a waste product," researcher says May 09, 2022
<ѻý>Novel Combo Falters in Metastatic Triple-Negative Breast Cancerѻý> No PFS benefit with addition of ceralasertib to olaparib May 05, 2022
<ѻý>Screening, Early Detection Remain Keys to Lower Cancer Mortalityѻý> Presidential panel sets course to remove barriers, increase services, and improve uptake May 05, 2022
<ѻý>Antibody-Drug Conjugate Promising for Breast Cancer With Brain Metsѻý> High intracranial response rates with trastuzumab-deruxtecan observed in TUXEDO-1 trial May 04, 2022
<ѻý>Young Cancer Survivors Face Higher Risk of Death From Second Malignanciesѻý> Study finds 25% higher risk of secondary cancers versus general public, 84% higher risk of death May 04, 2022
<ѻý>Corticosteroids Linked to Pain Events in Patients With Sickle Cell Diseaseѻý> Hospitalization risk for vaso-occlusive episodes four times higher after exposure May 02, 2022
<ѻý>Durvalumab Combinations Push the Response Envelope in Unresectable NSCLCѻý> Big increases in response, disease control with the addition of anti-CD73, anti-NKG2A agents May 02, 2022
<ѻý>Longer Ischemia Time Not Tied to Higher Complication Rate in Free-Tissue Transferѻý> Main focus of microvascular surgery should be best possible H&N reconstruction, researchers say May 01, 2022
<ѻý>Menstrual Cycles Point to Link Between Sex Hormones and Long QTѻý> Research suggests new tools for risk stratification and therapy May 01, 2022
<ѻý>Ambient Dirty Air May Put Some People at Higher Risk for Head and Neck Cancersѻý> Diesel particulate levels tied to increased oral and pharyngeal cancer incidence in one state May 01, 2022
<ѻý>Immunotherapy Before Head and Neck Surgery Doesn’t Add to Complicationsѻý> Definitive surgery can be conducted safely after neoadjuvant immunotherapy, researchers conclude May 01, 2022
<ѻý>End of the Line for a Failed Prostate Cancer Drugѻý> Orteronel misses mark in metastatic hormone-sensitive prostate cancer, after failures in mCRPC Apr 29, 2022
<ѻý>Another Robotic Approach for Bladder Cancer Removal Proves Its Mettleѻý> Robot-assisted laparoscopy with ICUD tied to better survival versus open surgery Apr 29, 2022
<ѻý>Program to Reduce Opioid Scripts Post-Surgery Worked for Thyroid Cancer Patientsѻý> Post-surgical intervention may help to reduce the risk of opioid addiction and overdose Apr 29, 2022
<ѻý>New Guidelines Target Cancer Risk in Rare GI Syndromesѻý> Task force focuses on diagnosis, management of gastrointestinal hamartomatous polyposis syndromes Apr 28, 2022
<ѻý>When Free Flaps Fail Twice, Another Try Can Be Successfulѻý> Second salvage attempt worked in 30% of cases Apr 28, 2022
<ѻý>Topical Antisepsis May Thwart SSIs in Upper Aerodigestive Tract Reconstructionѻý> Preoperative topical antisepsis mucosal preparation associated with 51% fewer infections Apr 28, 2022
<ѻý>Allo-Transplant With Omidubicel Hints at Longer-Term Benefits Tooѻý> "Viable" option for patients eligible for umbilical cord blood transplantation, investigator says Apr 27, 2022
<ѻý>Promising Data for Allo-Transplant After CAR T-Cell Failure in LBCLѻý> Durable responses with no unexpected or prolonged safety issues Apr 27, 2022
<ѻý>Another Link Between Prostate Cancer Hormone Tx and Impaired Cognitionѻý> Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
<ѻý>Eprenetapopt-Based Combo Impresses in TP53-Mutant AML/MDSѻý> 1-year relapse-free survival rate of 60% with maintenance therapy after transplant Apr 25, 2022
<ѻý>Stop Calling It Cancer; AI Gets a Win in Bladder Cancer; Lack of Price Transparencyѻý> News, features, and commentary about cancer-related issues Apr 22, 2022
<ѻý>What Does It Take to Confirm a Cancer Cluster?ѻý> Suspicions are raised at a New Jersey high school, but the road ahead is likely a long one Apr 22, 2022
<ѻý>Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dxѻý> Consistently low PSA levels failed to signal metastasis Apr 18, 2022
<ѻý>Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1ѻý> But response rate driven primarily by injected lesions, expert points out Apr 14, 2022
<ѻý>Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancerѻý> Responses in a majority of patients, evidence of durability with TTX-030, chemoimmunotherapy Apr 14, 2022
<ѻý>BTK Inhibitor Shows Potential in Immune Thrombocytopeniaѻý> Across doses, 40% of heavily pretreated patients responded to oral rilzabrutinib Apr 13, 2022
<ѻý>Dual Immunotherapy Improves PFS in Melanoma Resistant to Anti-PD-1ѻý> Six-month PFS rate more than doubled with nivolumab/ipilimumab versus ipilimumab alone Apr 13, 2022
<ѻý>Boosting Responses to Neoadjuvant Therapy in Resectable NSCLCѻý> Multi-drug platform study identifies promising durvalumab-based combinations Apr 12, 2022
<ѻý>Neoadjuvant Nivolumab a 'New Standard' in Lung Cancerѻý> "Another quantum leap in lung cancer therapy," expert says Apr 12, 2022
<ѻý>Genetic Score Shows Promise for Honing PSA Precisionѻý> Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
<ѻý>PARP Inhibitor-Based Triplet Promising in Endometrial Cancerѻý> Olaparib/cyclophosphamide/metformin combo appears effective in older, heavily pretreated patients Apr 11, 2022
<ѻý>Longer-Term Sotorasib Data 'Encouraging' in KRAS-Mutated NSCLCѻý> Prolonged tumor response seen in 2-year analysis Apr 11, 2022
<ѻý>DCIS Recurrence Often Represents a New Primary Breast Cancerѻý> Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
<ѻý>Bispecific Antibody-NK Cell Complex Impresses in Early Hodgkin/NHL Trialѻý> Objective responses in 89% of patients with no CRS, neurotoxicity, or graft-versus-host disease Apr 11, 2022
<ѻý>RT Prior to Mastectomy, Reconstruction Shows Promiseѻý> U.K. study demonstrates low complication rates and good aesthetic results Apr 08, 2022
<ѻý>Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients?ѻý> Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022